These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4190228)

  • 41. [Treatment of Basedow's disease by radioiodine].
    Vallée G
    Cah Coll Med Hop Paris; 1966 Jun; 7(6):365-72. PubMed ID: 5952667
    [No Abstract]   [Full Text] [Related]  

  • 42. [Ballistocardiography in patients with diffuse toxic goiter during I-131 treatment].
    Dozorets IuL; Bogdanovich GI; Seleznev LE
    Med Radiol (Mosk); 1969 Aug; 14(8):41-4. PubMed ID: 5396104
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term results with iodine-125 treatment for toxic diffuse goitre.
    Werner SC; Johnson PM; Goodwin PN; Wiener JD; Lindeboom GA
    Lancet; 1970 Oct; 2(7675):681-5. PubMed ID: 4195929
    [No Abstract]   [Full Text] [Related]  

  • 44. [Current approaches to the treatment of diffuse toxic goiter].
    Balabolkin MI
    Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of tumors of the thyroid gland].
    Blancher G
    Cah Coll Med Hop Paris; 1968 Dec; 9(14):1179-84. PubMed ID: 4195896
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
    Rasmussen AK; Feldt-Rasmussen UF
    Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of thyroid ablation on dysthyroid exophthalmos.
    Boyle IT; Greig WR; Thomson JA; Winning J; McGirr EM
    Proc R Soc Med; 1969 Jan; 62(1):19-23. PubMed ID: 5818232
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison between radioiodine and antithyroid therapy in the management of hyperthyroidism.
    Cassano C; Baschieri I; Cramarossa L
    Panminerva Med; 1965 Oct; 7(10):367-9. PubMed ID: 4158565
    [No Abstract]   [Full Text] [Related]  

  • 49. Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study.
    Eschmann SM; Thelen MH; Dittmann H; Bares R
    Exp Clin Endocrinol Diabetes; 2006 May; 114(5):222-6. PubMed ID: 16804795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of Basedow hyperthyroidism by protracted doses of radioactive iodine].
    Reboul J; Caille JM; Bellet M; Tessier JP
    Sem Hop; 1969 Jun; 45(27):1884-94. PubMed ID: 4308228
    [No Abstract]   [Full Text] [Related]  

  • 51. [Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].
    Urbannek V; Voth E; Moka D; Schicha H
    Nuklearmedizin; 2001 Aug; 40(4):111-5. PubMed ID: 11556200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Changes in the hemodynamics of patients with toxic goiter following treatment with radioactive iodine (according to radiocardiographic findings)].
    Katsevman AE
    Med Radiol (Mosk); 1971 Nov; 16(11):36-40. PubMed ID: 4950000
    [No Abstract]   [Full Text] [Related]  

  • 54. [Increase of urinary radioactivity after administration of tapazole in subjects pretreated with radioiodine. II. Behavior in acromegaly with normally functioning goiter].
    Minozzi M; Faggiano M; Nunziata V; Orio F
    Folia Endocrinol; 1966 Aug; 19(4):464-72. PubMed ID: 4170449
    [No Abstract]   [Full Text] [Related]  

  • 55. [Surgical management and prognosis of Basedow's disease].
    Ezaki H; Shigemitsu T; Araki M; Sasao T; Maruyama K
    Geka Chiryo; 1969 Nov; 21(5):534-41. PubMed ID: 4187614
    [No Abstract]   [Full Text] [Related]  

  • 56. TO-DAY'S DRUGS. TREATMENT OF THYROID DISORDERS.
    WAYNE E; BLACKBURN G; DAVIS RH
    Br Med J; 1964 Aug; 2(5407):493-7. PubMed ID: 14161993
    [No Abstract]   [Full Text] [Related]  

  • 57. [Hyperthyreosis in Basedow's disease].
    Välimäki MJ
    Duodecim; 1998; 114(5):447-54. PubMed ID: 11466937
    [No Abstract]   [Full Text] [Related]  

  • 58. [The treatment of hyperthyroidism with and indication for radioactive iodine].
    Klokke AR; van der Vijver JC
    Ned Tijdschr Geneeskd; 1995 Apr; 139(16):819-21. PubMed ID: 7537352
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of diffuse toxic goiter with 131-I.
    Dworkin HJ
    Semin Nucl Med; 1971 Oct; 1(4):399-410. PubMed ID: 4940743
    [No Abstract]   [Full Text] [Related]  

  • 60. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma].
    Hansen PE
    Ugeskr Laeger; 1983 Mar; 145(13):980-2. PubMed ID: 6190284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.